Sign inJoin waitlistJoin the waitlist

Karen Kotloff

Director of Infectious Diseases and Tropical Pediatrics · Univ of Maryland Sch of Med

Credentials: · · · ·

History

Pediatrics, UMSOM Division · University of Maryland, Baltimore
Present
University of Maryland, Baltimore
Present
Univ of Maryland Sch of Med
Present

Infectious Disease
University of Maryland School of Medicine
1981–1983
Pediatrics
UPMC Children's Hospital of Pittsburgh
1979–1980
Temple University School of Medicine
1975–1979
Washington University, B.A., Psychology, 1975
1971–1975

Research

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2021 · 8,425 citations
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
The Lancet · 2013 · First of 43 authors · Corresponding · 2,781 citations
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and…
Systematic review or meta-analysis · The Lancet · 2017 · 1,943 citations

Myron Levine
131 papers
Milagritos Tapia
88 papers
James Nataro
60 papers
James Platts-Mills
47 papers
Donald Thea
30 papers
Eric Houpt
30 papers
Kathleen Neuzil
30 papers
KO
Katherine O'Brien
28 papers
Laura Hammitt
28 papers
AR
Anna Roose
25 papers · 13 as a resident
CW
Cynthia Whitney
25 papers
EM
Eric Mintz
24 papers

Grants

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $52.7M · University of Maryland Baltimore
2019–2026
Bacteriophage-Based Approach for Managing Shigella Infections
National Institute of Allergy and Infectious Diseases · U01
PI · $6.9M · Intralytix, Inc.
2020–2026
Vaccine and Treatment Evaluation Units (VTEU) Protocol Development and Implementation for a Phase II Therapeutic Trial for Trichuris Trichiura
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $20.1M · University of Iowa
2013–2024
Advanced Development of a Filovirus Vaccine
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $15.3M · Janessen Vaccines and Prevention, Bv
2007–2017

Clinical trials

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
Principal investigator · Active not recruiting · Phase 4
University of Maryland, Baltimore
2020–2027
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
Principal investigator · Completed · Phase 1
University of Maryland, Baltimore
2011–2012
Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection
Principal investigator · Completed · Phase 1
University of Maryland, Baltimore
2010–2013
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Principal investigator · Terminated · Phase 2
University of Maryland, Baltimore
2010